Arcus scraps late-stage cancer trial after weak survival data

Arcus Biosciences said on Friday it would stop a late-stage study testing its experimental cancer drug combination in ...
Cure Today

Lenvima Combo Fails to Extend Survival in Esophageal Cancer

Lenvima and Keytruda with chemotherapy did not significantly improve OS in metastatic ESCC compared to Keytruda and chemotherapy alone. Median OS was 17.6 months in the Lenvima arm versus 15.5 months ...

Systematic Review and Meta-Analysis Confirms TissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk …

By integrating data across multiple studies, this analysis confirms that TissueCypher provides consistent, reproducible ...
WBAL-TV

What can be that can limit the risk of developing Esophageal Cancer?

IN THIS MORNING’S MEDICAL ALERT, APRIL IS ESOPHAGEAL AWARENESS MONTH. AND HERE TO TELL US ABOUT THE DISEASE, WHO IT AFFECTS, AND THE WARNING SIGNS IS PRESIDENT AND CEO OF THE ESOPHAGEAL CANCER ACTION ...

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful improvement with toripalimab plus ...
WVEC

Here's what to know about esophageal cancer following Rep. Gerry Connolly's death

FAIRFAX, Va. — Longtime Virginia Rep. Gerry Connolly passed away Wednesday morning following a battle with esophageal cancer. His family said in a statement that he passed away peacefully surrounded ...